Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -5,777 | -2,561 | -886 | 1,224 | 1,229 |
| Other Working Capital | -3,140 | 1,732 | -1,600 | -2,320 | -1,102 |
| Other Operating Activity | -4,201 | -5,203 | -8,533 | -8,941 | -13,110 |
| Operating Cash Flow | $-13,118 | $-6,032 | $-11,019 | $-10,037 | $-12,983 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,716 | -5,577 | -839 | -476 | -3,649 |
| Purchase Sale Intangibles | N/A | 0 | -98 | -195 | N/A |
| Other Investing Activity | 38 | 53 | 5,169 | 2,567 | -1,753 |
| Investing Cash Flow | $-16,678 | $-5,524 | $4,232 | $1,896 | $-5,402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,812 | 1,000 | N/A | N/A | N/A |
| Debt Repayment | -3,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 144 | 24,268 | 0 | 11,779 | 20,000 |
| Common Stock Repurchased | 0 | -226 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -1,460 | 0 | -1,517 | -1,430 |
| Financing Cash Flow | $24,956 | $23,582 | $0 | $10,262 | $18,570 |
| Exchange Rate Effect | N/A | N/A | N/A | 0 | -3 |
| Beginning Cash Position | 14,195 | 2,169 | 8,956 | 6,835 | 6,653 |
| End Cash Position | 9,355 | 14,195 | 2,169 | 8,956 | 6,835 |
| Net Cash Flow | $-4,840 | $12,026 | $-6,787 | $2,121 | $185 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,118 | -6,032 | -11,019 | -10,037 | -12,983 |
| Capital Expenditure | -16,716 | -5,577 | -937 | -671 | -3,649 |
| Free Cash Flow | -29,834 | -11,609 | -11,956 | -10,708 | -16,632 |